Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Skin Markers of Premature Ageing in Patients with COPD: Results Form COSYCONET.
Melzer T, Graf V, Kronseder A, Karrasch S, Kerschner M, Vogelmeier CF, Bals R, Alter P, Watz H, Fähndrich S, Behr J, Waschki B, Trudzinski FC, Jörres RA, Kahnert K. Melzer T, et al. Among authors: kahnert k. J Clin Med. 2024 Nov 19;13(22):6972. doi: 10.3390/jcm13226972. J Clin Med. 2024. PMID: 39598116 Free PMC article.
Dupilumab hilft bei COPD mit Eosinophilie.
Melzer T, Kahnert K. Melzer T, et al. Among authors: kahnert k. MMW Fortschr Med. 2024 Nov;166(Suppl 3):17. doi: 10.1007/s15006-024-4418-x. MMW Fortschr Med. 2024. PMID: 39482512 Review. German. No abstract available.
A1AT-Mangel: Substitution senkt Mortalität.
Melzer T, Kahnert K. Melzer T, et al. Among authors: kahnert k. MMW Fortschr Med. 2024 Oct;166(18):28-30. doi: 10.1007/s15006-024-4402-5. MMW Fortschr Med. 2024. PMID: 39448478 Review. German. No abstract available.
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial.
Higginson IJ, Brown ST, Oluyase AO, May P, Maddocks M, Costantini M, Bajwah S, Normand C, Bausewein C, Simon ST, Ryan K, Currow DC, Johnson MJ, Hart SP, Mather H, Krajnik M, Tanzi S, Ghirotto L, Bolton CE, Janowiak P, Turola E, Jolley CJ, Murden G, Wilcock A, Farsides B, Brown JM; BETTER-B consortium. Higginson IJ, et al. Lancet Respir Med. 2024 Oct;12(10):763-774. doi: 10.1016/S2213-2600(24)00187-5. Epub 2024 Sep 9. Lancet Respir Med. 2024. PMID: 39265600 Free article. Clinical Trial.
In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation.
Achter JS, Vega ET, Sorrentino A, Kahnert K, Galsgaard KD, Hernandez-Varas P, Wierer M, Holst JJ, Wojtaszewski JFP, Mills RW, Kjøbsted R, Lundby A. Achter JS, et al. Among authors: kahnert k. Cardiovasc Diabetol. 2024 Jul 18;23(1):258. doi: 10.1186/s12933-024-02338-4. Cardiovasc Diabetol. 2024. PMID: 39026321 Free PMC article.
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).
Trudzinski FC, Jörres RA, Alter P, Watz H, Vogelmeier CF, Kauczor HU, Thangamani S, Debic M, Welte T, Behr J, Kahnert K, Bals R, Herr C, Heußel CP, Biederer J, von Stackelberg O, Fähndrich S, Wouters EFM, Waschki B, Rabe KF, Herth FJF, Palm V; COSYCONET study group. Trudzinski FC, et al. Among authors: kahnert k. Respir Res. 2024 Jul 13;25(1):274. doi: 10.1186/s12931-024-02902-2. Respir Res. 2024. PMID: 39003487 Free PMC article.
Characterization and Mortality Risk of Impaired Left Ventricular Filling in COPD.
Abdo M, Watz H, Alter P, Kahnert K, Trudzinski F, Groth EE, Claussen M, Kirsten AM, Welte T, Jörres RA, Vogelmeier CF, Bals R, Rabe KF, Waschki B. Abdo M, et al. Among authors: kahnert k. Am J Respir Crit Care Med. 2024 Jul 10. doi: 10.1164/rccm.202310-1848OC. Online ahead of print. Am J Respir Crit Care Med. 2024. PMID: 38984876
106 results